Santhera Pharmaceuticals (SPHDF) Q2 2025 Earnings

29AprConfirmed
Jun 21
Q2 2024
Q3 2024
Q2 2025
-2.3
-1.53
-0.77
0

Details

Expected EPS
N/A
Actual EPS
-2.3012572
Surprise EPS
-2.3
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (SPHDF) has reported earnings of -2.3012572 per share for Q2 2025.

0 Comments

Share your thoughts